Table 1.
socio-demographic and clinical characteristics of diabetic foot ulcer patients receiving clinical care at Kenyatta National Hospital (N=152)
| n (%) | |
|---|---|
| Age group | |
| <40 | 35 (23%) |
| 40-50 | 47 (31%) |
| 50-60 | 36 (24%) |
| >60 | 34 (22%) |
| Gender | |
| Male | 93 (61%) |
| Female | 59 (39%) |
| Residence | |
| Urban | 113 (74%) |
| Rural | 39 (26%) |
| Type of diabetes | |
| Type 1 | 3 (2%) |
| Type 2 | 149 (98%) |
| Duration of diabetes (years) | |
| <5 | 32 (21%) |
| 5-10 | 34 (22%) |
| 10-15 | 42 (28%) |
| >15 | 44 (29%) |
| Duration of diabetic foot ulcer (months) | |
| <3 | 123 (80%) |
| 3-5 | 19 (13%) |
| >5 | 10 (7%) |
| Wagner ulcer grade | |
| I | 40 (26%) |
| II | 93 (61%) |
| III | 13 (9%) |
| IV | 6 (4%) |
| Episode of DFU | |
| I | 58 (38%) |
| II | 88 (58%) |
| III | 6 (4%) |
| Medication | |
| Metronidazole | 24 (80%) |
| Ceftriaxone | 3 (10%) |
| Ciprofloxacin | 1 (3%) |
| Metronidazole and ceftriaxone | 1 (3%) |
| Metronidazole and amoxicillin | 1 (3%) |